Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Extraordinary General Meeting on 12 November 2015



Avignon, 22nd October 2015 - Naturex, the global leader in specialty plant-based natural ingredients, informs its shareholders of an Extraordinary General Meeting focusing on a resolution about the allocation of free shares following the new provisions of Act No. 2015-990 of August 6, 2015 for growth, activity and equal economic opportunities, law called "Macron".


This Extraordinary General Meeting will be held on:


Thursday 12 November 2015, at 6 pm

31 Avenue Pierre 1er de Serbie

75016 Paris


The shareholders are invited to consult on the Company's website (www.naturex.com) the preliminary notice to the Extraordinary General Meeting that has been published on 2nd October 2015, in the Official List n°118 (BALO – Bulletin des Annonces Légales Obligatoires) and that comprises the agenda, the draft resolutions and details on attending and voting.


In addition, other documents and information related to this Extraordinary General Meeting (Report of the Board of Directors, report of the Statutory Auditors, voting form ...) are also posted online and made available at Naturex's head office, in compliance with the French legal and regulatory provisions.


 


You can receive all financial information of Naturex free of charge by signing up at: www.naturex.com



  • Financial schedule











    - Q3 2015 sales 4 November 2015
    - Q3 2015 results 30 November 2015



  • Upcoming events











    - Extraordynary General Meeting (Paris) 12 November 2015
    - ACTIONARIA tradeshow (Paris) 20 and 21 November 2015


 


Naturex has been listed since October 1996 on Euronext in Paris, Segment B








NATUREX Total number of shares comprising the share capital: 9,221,113 (September 2015)

ISIN FR0000054694



Naturex is a component of the CACT, Enternext CAC PEA-PME 150, CAC Small & Mid, CAC Small, Gaïa Index.

Naturex is eligible for the "long only" Deferred Settlement Service (SRD) and French equity plans (PEA and PEA-PME).

Naturex established a Sponsored Level 1 American Depositary Receipt (ADR) program in the United States. Under this facility, Naturex's ADRs are traded over-the-counter in the United States under the symbol NTUXY.



TICKER: NRX - Reuters: NATU.PA - Bloomberg: NRX:FP - DR SYMBOL: NTUXY

 


About Naturex


Naturex is the global leader in speciality plant-based natural ingredients. The Group is organised around three strategic markets (Food & Beverage, Nutrition & Health and Personal Care) and produces and markets speciality plant-based ingredients for the food, nutraceutical, pharmaceutical and cosmetic industries.


Naturex's head office is based in Avignon. The company employs 1,700 people with 8 sourcing offices located throughout the world and high-performance manufacturing operations across 15 sites in Europe, Morocco, the United States, Brazil, Australia and India. It also has a global commercial presence through a dedicated network of sales offices in more than 20 countries.



  • Contacts







Carole Alexandre

Investor Relations

Tel.: +33 (0)4 90 23 78 28

[email protected]
Anne Catherine Bonjour

Actus Finance Press Relations

Tel.: +33 (0)1 53 67 36 93

[email protected]

Information réglementée
Communiqués de mise à disposition de documents :

- Modalités de mise à disposition des documents préparatoires à l'AG

Full and original press release in PDF:


http://www.actusnews.com/documents_communiques/ACTUS-0-41803-cp-naturex_221015.pdf

© Copyright Actusnews Wire

Recevez gratuitement par email les prochains communiqués de la société en vous inscrivant sur www.actusnews.com

Receive by email the next press releases of the company by registering on www.actusnews.com, it's free



Quelle: Actusnews

Like: 0
Share

Comments